MIT Schwarzman College of Computing welcomes 11 new faculty for 2025
The faculty members occupy core computing and shared positions, bringing varied backgrounds and expertise to the MIT community.
The faculty members occupy core computing and shared positions, bringing varied backgrounds and expertise to the MIT community.
The associate professor aims to help the department continue to be a worldwide leader in education, biological sciences, and fundamental research.
Speakers at MIT’s Aging Brain Initiative symposium described how immune system factors during aging contribute to Alzheimer’s, Parkinson’s and other conditions. The field is leveraging that knowledge to develop new therapies.
A new study identifies genetic modifications that make these immune cells, known as CAR-NK cells, more effective at destroying cancer cells.
The findings may offer a new way to help heal tissue damage from radiation or chemotherapy treatment.
MIT researchers traced chemical fossils in ancient rocks to the ancestors of modern-day demosponges.
A new study finds over half the drugs approved this century cite government-funded research in their patents.
Chemotherapy-induced injury of organ tissue causes inflammation that awakens dormant cancer cells, which may cause new tumors to form.
MIT researchers have dramatically lowered the error rate of prime editing, a technique that holds potential for treating many genetic disorders.
The findings may redefine how cell identity is established and enable the creation of more sophisticated engineered tissues.
The longtime MIT professor and Nobel laureate was a globally respected researcher, academic leader, and science policy visionary who guided the careers of generations of scientists.
Researchers developed an approach to study where proteins get made, and characterized proteins produced near mitochondria, gaining potential insights into mitochondrial function and disease.
Researchers developed a tool to recreate cells’ family trees. Comparing cells’ lineages and locations within a tumor provided insights into factors shaping tumor growth.
The MIT community celebrates their fellow staff members’ talent and dedication to the Institute.
A new approach for testing multiple treatment combinations at once could help scientists develop drugs for cancer or genetic disorders.